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Abstract The amino acid sequence of Fuc-TIX is very highly
conserved between mouse and human. The number of non-
synonymous nucleotide substitutions of the Fuc-TIX gene
between human and mouse was strikingly low, and almost
equivalent to that of the K-actin gene. This indicates that Fuc-
TIX is under a strong selective pressure of preservation during
evolution. The human Fuc-TIX (hFuc-TIX) showed a unique
characteristics, i.e. hFuc-TIX was not activated by Mn2+ and
Co2+, whereas hFuc-TIV and hFuc-TVI were activated by the
cations. The hFuc-TIX transcripts were abundantly expressed in
brain and stomach, and interestingly were detected in spleen and
peripheral blood leukocytes.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
The Lewis x (Lex) carbohydrate epitope, which is de¢ned as
GalL1,4(FucK1,3)GlcNAc, is synthesized by transferring a fu-
cose (Fuc) to the N-acetylglucosamine (GlcNAc) residue of
the type 2 chain, GalL1,4GlcNAc, with an K1,3-linkage.
This fucose transfer is catalyzed by K1,3-fucosyltransferase
(K1,3Fuc-T). So far, the human genes encoding ¢ve
K1,3Fuc-Ts (Fuc-TIII, IV, V, VI and VII or FUT3, 4, 5, 6
and 7) have been cloned [1^6]. In a previous paper, we re-
ported the molecular cloning of a new member of the
K1,3Fuc-T family in the mouse and named the enzyme mouse
Fuc-TIX (mFuc-TIX or mFUT9) [7].
CD15 is one of the di¡erentiation markers of the cells, and
the CD15 epitope has been determined as the Lex carbohy-
drate structure. Several immunohistochemical studies have de-
tected CD15 antigens in certain neuronal cells and glial cells
in the central nervous system (CNS) of humans and rodents
[8^10]. The expression of CD15 antigens in the CNS is devel-
opmentally regulated, and considered to play a role in neuro-
nal development. In our previous study, mFuc-TIX was iden-
ti¢ed as the most likely candidate for the enzyme synthesizing
the Lex structure (CD15 epitope) in the mouse CNS [7].
Some K1,3Fuc-Ts are known to be polymorphic in human.
Three kinds of null alleles of the Fuc-TIII (Le) gene, named
le1, le2 and le3 alleles, are widely distributed in the Japanese
population [11^13]. Homozygotes of null Fuc-TVI alleles were
also found in some populations [14]. In bovine, there is only
one gene, named futb, corresponding to the hFuc-TV-hFuc-
TIII-hFuc-TVI gene cluster [15]. In addition, the mouse gene
orthologous to the futb gene seems to be a pseudogene [16]. In
this sense, the hFuc-TIII, hFuc-TV and hFuc-TVI genes are
regarded as non-essential for individual ontogeny, and there-
fore their sequences are not conserved among species.
Mice and humans possess functional Fuc-TIV and Fuc-
TVII genes [3^6,16,17]. The distribution of Fuc-TVII is lim-
ited to speci¢c tissues and cell populations such as leukocytes
and high endothelial cells of the venule [18]. Fuc-TVII ap-
parently participates in the synthesis of sialyl Lewis x (sLex)
epitopes in leukocytes: this epitope is required for leukocyte
tra⁄cking [18]. However, Fuc-TVII cannot synthesize the
CD15 (Lex) epitope [4,5,19]. Fuc-TIV is ubiquitously ex-
pressed in various tissues, and probably participates in
CD15 epitope synthesis in some tissues, but its biological
function remains to be elucidated [16].
In this study, we cloned a human gene, named hFuc-TIX,
orthologous to the mFuc-TIX gene, and analyzed its charac-
teristics and tissue distribution. Interestingly, the nucleotide
and amino acid sequences of hFuc-TIX were very highly con-
served in comparison with those of mFuc-TIX [7]. This indi-
cates that Fuc-TIX has been under a strong selective pressure
during its evolution, suggesting that it is essential for ontog-
eny.
2. Materials and methods
2.1. cDNA cloning and sequencing of the hFuc-TIX gene
A cDNA library derived from a human gastric mucosa was con-
structed in our laboratory (Ikehara et al., unpublished). We screened
the human stomach cDNA library with a mFuc-TIX cDNA probe
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encompassing the full-length open reading frame (ORF), and obtained
several clones encoding the hFuc-TIX gene. The inserts were subjected
to nucleotide sequencing.
2.2. Calculation of the numbers of synonymous and non-synonymous
nucleotide substitutions
To calculate the numbers of synonymous and non-synonymous
nucleotide substitutions in Fuc-T genes between mouse (or other spe-
cies) and human, we employed the ODEN program [20] of Supernig
at the National Institute of Genetics, Japan.
2.3. Flow cytometric analysis of Namalwa cells stably expressing the
hFuc-TIX gene and assaying of K1,3Fuc-T activity
Namalwa cells stably expressing the hFuc-TIX gene were estab-
lished, and subjected to £ow cytometry analysis, using SSEA-1
(anti-Lex ; Developmental Studies Hybridoma Bank, University of
Iowa, Ames, IA, USA) [21], AH6 (anti-Lewis y (Ley)) [22] and
CSLEX-1 (anti-sLex) [23] and assaying of K1,3Fuc-T activity using
pyridylaminated (PA) oligosaccharides, as described previously [7].
2.4. Quantitative analysis of K1,3Fuc-T transcripts in various human
tissues using the competitive reverse transcription-polymerase chain
reaction (competitive RT-PCR) method
The competitive RT-PCR methods for the measurement of the
transcripts for the hFuc-T III, IV, V, VI, VII genes have been de-
scribed in detail in our previous paper [24]. To quantify the hFuc-
TIX transcripts by competitive RT-PCR, a competitor DNA plasmid
(pBS-hFT9d) was prepared by deleting the 113-bp Nhe -NsiI fragment
from the standard DNA (pBS-hFT9s) which encodes the full-length
ORF of the hFuc-TIX gene. A pair of PCR primers (forward primer,
5P-GGCAAGCATTTGGAGAATATGTCAAT-3P and reverse prim-
er, 5P-ACCAACAGACTTATATTCTTGATGCC-3P) ampli¢ed 398-
bp and 285-bp fragments from pBS-hFT9s and pBS-hFT9d, respec-
tively. cDNA samples were prepared from various human tissues by
the method described previously [7,24]. The PCR conditions for the
hFuc-TIX gene were as follows: a pre-PCR heating step at 95‡C for
11 min, followed by 45 cycles of 1 min at 95‡C, 1.5 min at 65‡C, and
2 min at 72‡C. To ascertain the e⁄ciency of cDNA preparation from
total RNAs, measurement of the L-actin transcripts in each sample
was performed.
2.5. In situ hybridization and immunohistochemical analyses
Surgically resected stomach specimens for in situ hybridization were
prepared as described previously [7]. The antisense and sense RNA
probes, at the nucleotide positions 655^835 of hFuc-TIX cDNA, la-
beled with digoxigenin were synthesized using a Dig RNA Labeling
Kit (Boehringer Mannheim) according to the supplier’s manual. The
hybridization and signal detection procedures were performed as de-
scribed previously [7].
Immunohistochemistry was performed with monoclonal antibodies,
PM-81 (anti-Lex) [25] and AH6 (anti-Le y), by the method described
previously [26].
2.6. Construction of a phylogenetic tree of the K1,3Fuc-T family
We used amino acid sequences for six human [1^6], three mouse
[7,16,17], one rat [27], one bovine [15], one chicken [28], two zebra¢sh
[29] and four Caenorhabditis elegans [30] genes. These 18 sequences
were multiply aligned, and all positions with gaps were eliminated,
resulting in the alignment of 356 amino acid residues. Clustal W [31]
was used for multiple alignment and the neighbor-joining method [32]
was used to construct a tree. We also performed a bootstrap analysis
to gain a statistical measure of con¢dence in the phylogenetic tree. By
bootstrap analysis, a total of 1000 trees were generated from the
initial data set, and the percentage of trees containing a particular
clade was measured.
3. Results
3.1. A putative amino acid sequence of hFuc-TIX deduced from
the cDNA sequence which is highly conserved between
mouse and human
The 3019-bp nucleotide sequence of the hFuc-TIX cDNA
was registered by us in DDBJ/EMBL/GenBank with the ac-
cession number AB023021. The putative amino acid sequence
predicted from the nucleotide sequence encodes a typical type
II membrane protein, and is very similar to that of mFuc-
TIX, i.e. only three amino acid residues, Val-37 to Ile, Thr-
237 to Ala and Phe-292 to Tyr, di¡er among 359 amino acids
(Fig. 1). The consensus amino acid sequence for the members
of the K1,3Fuc-T family [33], FxL/VxFENS/TxxxxYxTEK, is
conserved in the hFuc-TIX sequence.
3.2. Synonymous and non-synonymous substitutions of the
members of the Fuc-T gene family
We calculated the numbers of synonymous (dS) and non-
synonymous (dN) nucleotide substitutions between mFuc-TIX
and hFuc-TIX genes to establish if there is some signi¢cant
evolutionary pressure for maintaining the primary structure of
the enzyme (dS : number of substitutions per site which cause
no amino acid replacement; dN : number of substitutions per
site which cause amino acid replacement) (Table 1). The other
Fuc-T genes, H (FUT1), Fuc-TIII (FUT3), Fuc-TIV (FUT4),
Fuc-TVII (FUT7) and FUT8 genes, were also analyzed to
determine their dS and dN values (Table 1). The mouse Fuc-
TIII and FUT8 genes have not been cloned, therefore the
bovine orthologue (futb) for hFuc-TIII gene and the porcine
FUT8 gene were compared with the respective human genes.
We considered that it was essentially not a problem to use
di¡erent species to calculate dS and dN, because they started
to diverge more or less at the same time. The Fuc-TIX gene
showed the lowest dN value (0.005), followed by the FUT8
gene (0.021), among the six members of the Fuc-T gene fam-
ily. The di¡erence in dN values between the Fuc-TIX gene and
the others was almost 40-fold. On the other hand, the dS
Fig. 1. A schematic diagram of the primary structure of hFuc-TIX.
Three amino acid substitutions between hFuc-TIX and mFuc-TIX
are presented at positions 37, 237 and 292. A putative transmem-
brane domain is indicated with a dark shaded box. The amino acid
sequence and position of the K1,3Fuc-T motif conserved in all
K1,3Fuc-Ts, including those of Helicobacter pylori [33], is presented.
A possible N-glycosylation site is indicated with an asterisk.
Table 1
Synonymous (dS) and non-synonymous (dN) substitutions per site of
K1,3Fuc-T genes
Gene La dS dN Species pair
H (FUT1) 368 0.938 0.148 mouse vs. human
Fuc-TIII (FUT3) 366 0.516 0.218 bovine vs. human
Fuc-TIV (FUT4) 408 0.734 0.159 mouse vs. human
Fuc-TVII (FUT7) 343 0.950 0.111 mouse vs. human
FUT8 576 0.331 0.021 porcine vs. human
Fuc-TIX (FUT9) 360 0.527 0.005 mouse vs. human
histone H4b 101 0.228 0.001 mouse vs. human
K-actinb 376 0.587 0.002 mouse vs. human
aNumber of codons compared.
bLi et al. [40].
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values for Fuc-TIX gene (0.527) and the others (0.331-0.950)
were similar.
3.3. Flow cytometry analysis of Namalwa cells transfected with
the hFuc-TIX gene and measurement of K1,3Fuc-T activity
of hFuc-TIX towards oligosaccharides
Namalwa-hFT9 cells, stably expressing the hFuc-TIX
cDNA, were analyzed by £ow cytometry. Namalwa-hFT9
cells showed a positive peak with SSEA-1 (anti-Lex) and
AH6 (anti-Ley), but not with CSLEX-1 (anti-sLex) (data not
shown). In contrast, Namalwa-hFT4 cells (stable transform-
ant with the hFuc-TIV gene) showed positive peaks with all
three antibodies, SSEA-1, AH6 and CSLEX-1, although the
positive peak with CSLEX-1 was very weak (data not shown).
The K1,3Fuc-T activities of hFuc-TIX were measured
against PA oligosaccharides, i.e. lacto-N-neotetraose-PA
(LNnT-PA), lacto-N-tetraose-PA (LNT-PA) and K2,3-sialyl
lacto-N-tetraose-PA (sialyl-LNnT-PA). hFuc-TIX exhibited
activity against LNnT-PA, resulting in the synthesis of Lex
epitope, but no activity against LNT-PA or sialyl-LNnT-
PA, resulting in no synthesis of the Lewis a (Lea) or sLex
epitope, respectively (data not shown).
Thus, hFuc-TIX showed almost the same results of £ow
cytometry analysis and K1,3Fuc-T activities as mFuc-TIX [7].
3.4. Activation of K1,3Fuc-Ts in the presence of Mn2+ or Co2+
Three human K1,3Fuc-Ts, i.e. hFuc-TIX, hFuc-TIV and
hFuc-TVI, were examined for activity against LNnT-PA in
the presence of Mn2 or Co2 (Fig. 2). Interestingly, hFuc-
TIX was not activated at any concentration of Mn2 or Co2,
moreover it was markedly suppressed by Mn2 and Co2
(Fig. 2A). In contrast, hFuc-TIV was markedly activated in
the presence of Mn2, but less so in that of Co2 (Fig. 2B).
hFuc-TVI was also markedly activated by both Mn2 and
Co2 (Fig. 2C).
3.5. Tissue distribution and quantitative measurement of
six human K1,3Fuc-T transcripts
The amounts of six human K1,3Fuc-T transcripts expressed
in various tissues were measured by competitive RT-PCR
(Table 2). hFuc-TIII was abundantly expressed in gastrointes-
tinal tissues, i.e. stomach, jejunum and colon, and faintly ex-
pressed in spleen, lung, kidney and cervix uteri. hFuc-TIII was
not detected in brain, liver, adrenal cortex or peripheral blood
leukocytes (PBL). hFuc-TIV was found to be ubiquitously
expressed in all tissues examined and it was abundantly ex-
pressed in cervix uteri. hFuc-TV was not expressed in any
tissues examined, except for spleen in which it was faintly
expressed. The tissue distribution of hFuc-TVI was similar
to that of hFuc-TIII, except that hFuc-TVI was expressed
positively in liver whereas hFuc-TIII was not. hFuc-TVI
was much more abundant in kidney than hFuc-TIII. hFuc-
Fig. 2. Activation of hFuc-TIX, hFuc-TIV and hFuc-TVI by Mn2
or Co2. The activities toward LNnT-PA were measured at various
concentrations of Mn2 (E) or Co2 (F). The activity in the absence
of the dications is presented as 100% activity.
Table 2
Quantitative analysis of transcripts of six K1,3Fuc-T genes in various human tissues by competitive RT-PCR
Expression levels of K1,3Fuc-Ts relative to the level of L-actin (%)
Fuc-TIII Fuc-TIV Fuc-TV Fuc-TVI Fuc-TVII Fuc-TIX
Forebrain 6 0.001 0.58 6 0.001 0.01 6 0.001 0.53
Stomach (antrum) 2.42 1.83 6 0.001 0.27 6 0.001 0.73
Stomach (corpus) 1.87 1.07 6 0.001 0.06 6 0.001 0.37
Jejunum 13.66 2.33 6 0.001 0.86 6 0.001 6 0.001
Colon 2.90 0.43 6 0.001 0.41 6 0.001 6 0.001
Liver 6 0.001 0.39 6 0.001 0.14 6 0.001 6 0.001
Spleen 0.02 0.25 0.02 0.004 0.13 0.004
Lung 0.01 0.01 6 0.001 6 0.001 6 0.001 6 0.001
Kidney 0.34 1.13 6 0.001 3.18 6 0.001 6 0.001
Adrenal cortex 6 0.001 0.35 6 0.001 6 0.001 6 0.001 6 0.001
Cervix uteri 0.12 5.14 6 0.001 0.07 6 0.001 6 0.001
PBL 6 0.001 0.29 6 0.001 6 0.001 0.15 0.01
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TVII was detected in spleen and PBL. hFuc-TIX was mark-
edly expressed in forebrain and stomach, i.e. in both the an-
trum and corpus of the stomach, and, interestingly, was de-
tected in spleen and PBL. hFuc-TIX was not expressed in
kidney at all. In this regard, hFuc-TIX di¡ers from mFuc-
TIX which is abundantly expressed in mouse kidney [7].
3.6. Immunohistochemical analysis of Lex and Ley expression
and in situ hybridization analysis of hFuc-TIX transcripts
in the antrum portion of human gastric mucosa
A stomach specimen of a secretor individual, whose secre-
tor (Se) genotype is Se1/Se1 [26], was subjected to immuno-
histochemical analysis for Lex and Ley expression and in situ
hybridization with the hFuc-TIX probe. As can be seen in
Fig. 3A,B, the Lex antigens were mainly positive in the
glandular compartments of the pyloric mucosa. In contrast,
the Ley antigens were detected both in the glandular compart-
ments and in the pit of the gastric mucosa. The hFuc-TIX
transcripts were localized in the glandular compartments
alone, being well co-localized with the Lex antigens (Fig.
3C).
3.7. A phylogenetic tree of the K1,3Fuc-T gene family
We performed a FASTA search [34], and BLAST search
[35] of the DDBJ/EMBL/GenBank International Nucleotide
Sequence Database to identify the genes homologous to the
hFuc-TIX gene. We used two speci¢c search programs, tfastx
and tblastn, which compare amino acid sequences with a
DNA database. Mammalian, chicken, zebra¢sh, C. elegans,
Helicobacter pylori, Drosophila melanogaster, and Vibrio cho-
lerae genes were retrieved, while no members of the K1,2 or
K1,6Fuc-T gene families were found to show homology with
the hFuc-TIX gene.
The root was determined by assuming that C. elegans genes
are located as outgroups (Fig. 4). The phylogenetic tree indi-
cates that the Fuc-T genes evolved by independent gene du-
plication between vertebrates and C. elegans. There are four
clusters in the vertebrate Fuc-T gene family, the Fuc-TIX gene
subfamily being the ¢rst to diverge from the ancestral gene.
Two zebra¢sh K1,3Fuc-Ts, zFT1 and zFT2, which are devel-
opmentally regulated in embryogenesis, form a cluster with
mFuc-TIX and hFuc-TIX.
Fig. 3. Immunohistochemical staining with PM-81 (anti-Lex) and AH6 (anti-Ley) and in situ hybridization with the hFuc-TIX probe on the an-
trum portion of human gastric mucosa. Serial sections were immunohistochemically stained with PM-81 (A) and AH6 (B). C shows the positive
signals detected with the antisense probe of segment 655^835, and D shows the negative signals with the sense probe of segment 655^835. The
scale bar represents 10 Wm.
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4. Discussion
hFuc-TIX can synthesize the Lex and Ley epitopes, but not
the Lea or sLex epitopes, in contrast to hFuc-TIV’s low, but
apparently positive activity of sLex synthesis. These character-
istics of hFuc-TIX were almost the same as those of mFuc-
TIX. In the present study, we found that Mn2 and Co2 ions
did not activate the hFuc-TIX activity at all.
Mollicone et al. reported that human brain homogenates
exhibited activity for Lex synthesis, but not for sLex synthesis
[36,37]. The enzymes expressed in brain and leukocytes had
similar levels of activity, i.e. both showed similar Km values
for GDP-fucose and H-type 2 compounds, the same optimum
pH, and were resistant to N-ethylmaleimide. However, they
di¡ered in the enzyme activity when activated by dications.
The enzyme(s) in leukocytes exhibited only 10^15% of the
activity in the presence of Co2 as compared to Mn2, where-
as the activity of brain enzyme(s) did not di¡er in the presence
of Mn2 or Co2 [36,37]. Foster et al. indicated that the
enzyme puri¢ed from human neuroblastoma cells exhibited
a level of activity in the presence of 10 mM Co2 that was
75% of that in the presence of 10 mM Mn2 [38]. The char-
acteristics of hFuc-TIX determined in the present study were
most similar to those of the enzyme(s) in adult brain [36].
However, there was some discrepancy between previous stud-
ies [36^38] and our study as to the characteristics of K1,3Fuc-
T activities which can be explained as follows. As demon-
strated in Table 2 in the present study, many tissues contain
multiple K1,3Fuc-Ts. The previous studies measured the ac-
tivities directed by mixed enzymes in tissue homogenates,
while we measured the activities of the recombinant enzymes.
In tissue homogenates, there may still be unknown K1,3Fuc-
Ts, the genes of which have not been cloned.
Cameron et al. [39] reported the tissue distribution of three
hFuc-Ts, i.e. hFuc-TIII, V and VI, on Northern analysis and
semi-quantitative RT-PCR. We employed the competitive
RT-PCR method in the present study because of the following
advantages. Competitive RT-PCR enabled us for the ¢rst time
to compare all six K1,3Fuc-Ts in terms of the level of relative
amounts of transcripts in various human tissues. The small
amounts of transcripts, which could not be detected by North-
ern analysis, were quantitatively detected by this sensitive
method. Fuc-TIV is believed to be a single enzyme capable
of Lex (CD15) synthesis in myeloid tissues. It is worth noting
that hFuc-TIX was also expressed in spleen and PBL almost
at the same level as hFuc-TIV. We will examine whether
hFuc-TIX and hFuc-TIV are expressed in cells of di¡erent
subpopulations in PBL or together in the same cells. hFuc-
TIX was not expressed in human kidney at all, whereas
mFuc-TIX was most abundantly expressed in mouse kidney
as demonstrated in our previous study [7]. There may be spe-
cies-speci¢c and tissue-speci¢c regulation of the Fuc-TIX gene.
In this study, we detected both hFuc-TIX and hFuc-TIV ex-
pression almost at the same level in forebrain, while we did
not detect mFuc-TIV in a previous study [7]. This discrepancy
may be attributed to the di¡erent areas of brain examined, or
to a species-speci¢c regulation as in kidney.
The co-localization of hFuc-TIX transcripts with the Lex
antigens in the glandular compartments of the stomach
strongly suggested that hFuc-TIX is involved in the synthesis
of Lex antigens in stomach. However, the absence of hFuc-
TIX in the foveolar cells in the gastric pits indicated that some
other K1,3Fuc-T(s) are involved in Ley synthesis, because gas-
tric mucosa expressed four kinds of K1,3Fuc-Ts, i.e. hFuc-
TIII, IV, VI and IX, as shown in Table 2.
The position of Fuc-TIX in the phylogenetic tree indicates
that the Fuc-TIX subfamily was the ¢rst to diverge in verte-
brates. CFT1, a chicken homologue (probably orthologue) of
Fuc-TIV, is clustered with the mammalian Fuc-TIV subfam-
ily. This suggests that a chicken orthologue of Fuc-TIX may
be found in the Fuc-TIX subfamily. It is of interest to know
to what extent the Fuc-TIX sequence is evolutionarily con-
served in non-mammal vertebrates. The numbers of non-syn-
onymous substitutions (dN) of protein coding gene regions are
known to vary considerably. Genes for conservative proteins
such as histones and actins show very low dN values (0.001
and 0.002, respectively, between mouse and human [40]), be-
cause selective constraints are strong. It should be emphasized
that the dN value of the Fuc-TIX gene is as low as those of
histone and K-actin genes. The very low dN value of the Fuc-
TIX gene clearly indicates a strong selective pressure for the
preservation of the Fuc-TIX amino acid sequence during the
mammalian evolution. Recently, two zebra¢sh K1,3Fuc-T
genes, zFT1 and zFT2, were found to be expressed in embryo-
genesis [29]. hFuc-TIX and mFuc-TIX form a cluster with
zFT1 and zFT2 in the phylogenetic tree. Fuc-TIX may pos-
sibly be involved in mammalian embryogenesis, and play an
essential role for ontogeny.
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Fig. 4. Phylogenetic tree of K1,3Fuc-Ts. The branch lengths indicate
the evolutionary distances between di¡erent genes. 7 indicates the
gene duplication and b the speciation. Four cosmid clone names
containing C. elegans genes are presented.
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